Advertisement

Neurological Sciences

, Volume 36, Issue 2, pp 309–313 | Cite as

Plasma miR-454-3p as a potential prognostic indicator in human glioma

  • Naiyuan Shao
  • Lei Wang
  • Lian Xue
  • Rong Wang
  • Qing LanEmail author
Original Article

Abstract

microRNAs (miRNAs) are a class of small non-coding RNAs, approximately 21–25 nucleotides in length. Recently, some researchers have demonstrated that plasma miRNAs are sensitive and specific biomarkers of various cancers. Using quantitative real-time PCR, the expression levels of miR-454-3p were compared between pre-operative plasmas from 70 glioma patients and 70 healthy controls, and between these pre-operative and post-operative plasmas. Kaplan–Meier analysis was used to evaluate the association of miR-454-3p with prognosis of glioma patients. The expression levels of miR-454-3p in plasma in glioma patients were significantly higher than that from healthy controls. The expression levels of miR-454-3p were higher in high grade gliomas than in low grade gliomas. The AUC of the expression of miR-454-3p in plasma for glioma diagnosis was 0.9063. The expression levels of miR-454-3p in the post-operative plasmas were significantly downregulated when compared to the pre-operative plasmas. Moreover, the prognosis of glioma with high miR-454-3p expression was significantly worse compared with that of glioma with low miR-454-3p expression. Our results suggested that plasma miR-454-3p could be a novel potential diagnostic biomarker for glioma.

Keywords

MiR-454-3p Glioma Diagnosis Prognosis 

Notes

Acknowledgments

This work was supported by National Natural Science Foundation of China Projects 31071046 and 81302197, Changzhou Science Development Project (CS20102010) and Changzhou Health Bureau Key Project (ZD201007).

Conflict of interest

The authors have declared no conflicts of interest.

Supplementary material

10072_2014_1938_MOESM1_ESM.doc (88 kb)
Supplementary material 1 (DOC 88 kb)

References

  1. 1.
    Siegel R, Naishadham D (2013) Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11–30CrossRefPubMedGoogle Scholar
  2. 2.
    Davis FG, McCarthy BJ (2001) Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 1(3):395–401CrossRefPubMedGoogle Scholar
  3. 3.
    Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269CrossRefPubMedGoogle Scholar
  4. 4.
    Cech TR, Steitz JA (2014) The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157(1):77–94CrossRefPubMedGoogle Scholar
  5. 5.
    Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297CrossRefPubMedGoogle Scholar
  6. 6.
    Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866CrossRefPubMedGoogle Scholar
  7. 7.
    Palanichamy JK, Rao DS (2014) miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet 5:54PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du F, Liu LJ, Liu YH, Liu XD, Jia JF, Li L, Wu ZL, Zhao G, Zhang ZG, Deng YC (2013) Identification of microRNA-205 as a potential prognostic indicator for human glioma. J Clin Neurosci 20(7):933–937CrossRefPubMedGoogle Scholar
  9. 9.
    Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006CrossRefPubMedGoogle Scholar
  10. 10.
    Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513–10518PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118(3):449–457CrossRefPubMedGoogle Scholar
  12. 12.
    Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K (2012) Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 31:97PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Ilhan-Mutlu A, Wagner L, Wohrer A, Furtner J, Widhalm G, Marosi C, Preusser M (2012) Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients. Cancer Invest 30(8):615–621CrossRefPubMedGoogle Scholar
  14. 14.
    Ilhan-Mutlu A, Wagner L, Wohrer A, Jungwirth S, Marosi C, Fischer P, Preusser M (2012) Blood alterations preceding clinical manifestation of glioblastoma. Cancer Invest 30(9):625–629CrossRefPubMedGoogle Scholar
  15. 15.
    Shen W, Song M, Liu J, Qiu G, Li T, Hu Y, Liu H (2014) MiR-26a promotes ovarian cancer proliferation and tumorigenesis. PLoS One 9(1):e86871PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC, Wu XN (2013) Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 5(5):1639–1642PubMedCentralPubMedGoogle Scholar
  17. 17.
    Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC, Chalasani N (2013) Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One 8(9):e74471PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G, Martelli F (2014) Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord 24(6):509–515CrossRefPubMedGoogle Scholar
  19. 19.
    Nair N, Kumar S, Gongora E, Gupta S (2013) Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem 376(1–2):33–40CrossRefPubMedGoogle Scholar
  20. 20.
    Zhu D, He X, Duan Y, Chen J, Wang J, Sun X, Qian H, Feng J, Sun W, Xu F, Zhang L (2014) Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors 7:148PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Zen K, Zhang CY (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32(2):326–348CrossRefPubMedGoogle Scholar
  22. 22.
    Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659CrossRefPubMedGoogle Scholar
  23. 23.
    Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14(3):249–256CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  • Naiyuan Shao
    • 1
    • 4
  • Lei Wang
    • 2
  • Lian Xue
    • 3
  • Rong Wang
    • 3
  • Qing Lan
    • 1
    Email author
  1. 1.Department of NeurosurgeryThe Second Affiliated Hospital of Soochow UniversitySuzhouChina
  2. 2.Xuzhou Central Hospital, Affiliated Hospital of Southeast UniversityXuzhouChina
  3. 3.Modern Medical Research CenterThird Affiliated Hospital of Soochow UniversityChangzhouChina
  4. 4.Department of NeurosurgeryThird Affiliated Hospital of Soochow UniversityChangzhouChina

Personalised recommendations